BUTITTA CYNTHIA M
SEC insider (Form 3/4/5 filer). CIK 0001222082. Director at Autolus Therapeutics plc (AUTL) and 3 other issuers. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in LONDON.
Companies BUTITTA CYNTHIA M has filed insider reports for
- Autolus Therapeutics plc (AUTL): Director
- UroGen Pharma Ltd. (URGN): Director
- Olema Pharmaceuticals, Inc. (OLMA): Director
- Century Therapeutics, Inc. (IPSC): Director
BUTITTA CYNTHIA M
CIK: 0001222082
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 29, 2026AUTL
Autolus Therapeutics plc
AwardDirectShare Option (Right to Buy)
47.5K shares- - Jun 29, 2026AUTL
Autolus Therapeutics plc
AwardDirectRestricted Share Units
31.7K shares- - Jun 22, 2026URGN
UroGen Pharma Ltd.
AwardDirectRestricted Stock Unit
8K shares- - Jun 22, 2026URGN
UroGen Pharma Ltd.
AwardDirectStock Option (right ot buy)
10K shares- - Jun 18, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
29.5K shares- - Nov 26, 2025URGN
UroGen Pharma Ltd.
ExerciseDirect2K shares- - Aug 26, 2025URGN
UroGen Pharma Ltd.
AwardDirectRestricted Stock Unit
8K shares- - Aug 26, 2025URGN
UroGen Pharma Ltd.
AwardDirectStock Option (right ot buy)
10K shares- - Jun 12, 2025IPSC
Century Therapeutics, Inc.
AwardDirectStock Option (right to buy)
44K shares- - Jun 11, 2025OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
24.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 29, 2026 |  AUTL Autolus Therapeutics plc | Award Share Option (Right to Buy) | 47,500 | - | - | Direct |
| Jun 29, 2026 | AUTL Autolus Therapeutics plc | Award Restricted Share Units | 31,667 | - | - | Direct |
| Jun 22, 2026 |  URGN UroGen Pharma Ltd. | Award Restricted Stock Unit | 8,000 | - | - | Direct |
| Jun 22, 2026 | URGN UroGen Pharma Ltd. | Award Stock Option (right ot buy) | 10,000 | - | - | Direct |
| Jun 18, 2026 |  OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 29,500 | - | - | Direct |
| Nov 26, 2025 | URGN UroGen Pharma Ltd. | Exercise | 2,000 | - | - | Direct |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | Award Restricted Stock Unit | 8,000 | - | - | Direct |
| Aug 26, 2025 | URGN UroGen Pharma Ltd. | Award Stock Option (right ot buy) | 10,000 | - | - | Direct |
| Jun 12, 2025 |  IPSC Century Therapeutics, Inc. | Award Stock Option (right to buy) | 44,000 | - | - | Direct |
| Jun 11, 2025 | OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 24,150 | - | - | Direct |
1-10 of 10 transactions